COGNITION THERAPEUTICS INC (CGTX) Stock Cash Flow
NASDAQ:CGTX - Nasdaq - US19243B1026 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.27M | -25.79M | -21.40M | -11.72M | -7.84M | |||
| Depreciation Amortization | 106.00K | 96.00K | 80.00K | 90.00K | 100.00K | |||
| Change In Working Capital | 3.99M | 4.85M | -940.00K | 2.84M | 3.07M | |||
| Other non cash items | 4.63M | 4.83M | 3.72M | 5.15M | 1.24M | |||
| OPERATING CASH FLOW | -25.55M | -16.02M | -18.53M | -3.63M | -3.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -30.00K | -147.00K | -170.00K | -30.00K | -10.00K | |||
| INVESTING CASH FLOW | -30.00K | -147.00K | -170.00K | -30.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -725.00K | -811.00K | -1.40M | -270.00K | 5.81M | |||
| Stock Issued/Repurchased | 14.60M | 5.33M | 6.94M | 44.53M | 50.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | 8.94M | -90.00K | |||
| FINANCING CASH FLOW | 14.63M | 4.52M | 5.55M | 53.20M | 5.77M | |||
| Exchange Rate Effect | N/A | 4.00K | 0.00 | -10.00K | -20.00K | |||
| CHANGE IN CASH | -10.95M | -11.64M | -13.15M | 49.53M | 2.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.55M | -16.02M | -18.53M | -3.63M | -3.43M | |||
| Capital Expenditure | -30.00K | -147.00K | -170.00K | -30.00K | -10.00K | |||
| FREE CASH FLOW | -25.58M | -16.16M | -18.70M | -3.66M | -3.44M | |||
All data in USD